Wealth Enhancement Advisory Services
ANIK icon

Wealth Enhancement Advisory Services’s Anika Therapeutics ANIK Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
15,577
+5,531
+55% +$82K ﹤0.01% 3409
2026
Q1 		$149K Buy
+10,046
New +$117K ﹤0.01% 3230

Other funds holding ANIK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's ANIK Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Anika Therapeutics (ANIK) stake by 55% in Q2 2026, buying an estimated $82K and bringing the position to 15,577 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Wealth Enhancement Advisory Services first reported a position in ANIK in Q1 2026 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Wealth Enhancement Advisory Services held 15,577 shares of Anika Therapeutics worth $243K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 5,531 Anika Therapeutics shares in Q2 2026, an estimated $82K.
  • Anika Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3409 holding.
  • Wealth Enhancement Advisory Services first reported a position in Anika Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.